Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies in the United States, with more than 30,000 new cases expected in 2018.
Read More
In 1993, Jon R. Katzenbach and Douglas K. Smith authored The Wisdom of Teams, a collection of observations and insights into how high-performance teams can be assembled and managed. Many of the principles elaborated in the book are applicable to team science for cancer research.
Read More
Pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent, according to statistics from the SEER database. Unfortunately, the last 30 years has not seen any significant improvement in survival for patients with this disease. Pancreatic cancer is projected to become the second leading cause of deaths due to cancer in the United States by 2030.
Read More
The next step in trying to increase the proportion of patients who respond to these therapies, therefore, is to understand who responds and why.
Read More
Stand Up To Cancer’s highly successful 2016 fundraising telecast will help keep up the pace of progress against cancer, according to Margaret Foti, PhD, MD (hc), chief executive officer of …
Read More
A whirlwind of activity and excitement is currently whipping through Los Angeles, Philadelphia, New York, and many places in between. Stand Up To Cancer (SU2C), the fundraising powerhouse launched by …
Read More
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our understanding of cancer and ways to fight it. It’s also a …
Read More
AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we asked the co-leader of the SU2C–Dutch Cancer Society Dream Team on Molecular Early Detection of Colorectal Cancer, Victor Velculescu, MD, PhD, about the work of the Dream Team and other efforts in this field of cancer research.
Read More
Guest Post by Emer Smyth, PhD
Assistant Director for the Stand Up To Cancer (SU2C) translational research grant programs, AACR
For AACR’s grants program, 2015 was indeed a successful year to reflect upon. Among many highlights, 2015 saw the forging of new relationships with funding partners such as Bayer and …
Read More